| Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium FF Tuon, MH Rigatto, CK Lopes, LK Kamei, JL Rocha, AP Zavascki International journal of antimicrobial agents 43 (4), 349-352, 2014 | 168 | 2014 |
| Multicenter prospective cohort study of renal failure in patients treated with colistin versus polymyxin B MH Rigatto, MS Oliveira, LV Perdigão-Neto, AS Levin, CM Carrilho, ... Antimicrobial agents and chemotherapy 60 (4), 2443-2449, 2016 | 140 | 2016 |
| Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study MH Rigatto, TF Behle, DR Falci, T Freitas, NT Lopes, M Nunes, LW Costa, ... Journal of Antimicrobial Chemotherapy 70 (5), 1552-1557, 2015 | 126 | 2015 |
| Polymyxin acute kidney injury: dosing and other strategies to reduce toxicity RL Nation, MHP Rigatto, DR Falci, AP Zavascki Antibiotics 8 (1), 24, 2019 | 110 | 2019 |
| Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia CH Kvitko, MH Rigatto, AL Moro, AP Zavascki Journal of Antimicrobial Chemotherapy 66 (1), 175-179, 2011 | 84 | 2011 |
| Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or … MH Rigatto, FJ Vieira, LC Antochevis, TF Behle, NT Lopes, AP Zavascki Antimicrobial agents and chemotherapy 59 (10), 6575-6580, 2015 | 82 | 2015 |
| Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection GS Medeiros, MH Rigatto, DR Falci, AP Zavascki International journal of antimicrobial agents 53 (2), 152-157, 2019 | 49 | 2019 |
| Severe infusion-related adverse events and renal failure in patients receiving high-dose intravenous polymyxin B JF John, DR Falci, MH Rigatto, RD Oliveira, TG Kremer, AP Zavascki Antimicrobial Agents and Chemotherapy 62 (1), 10.1128/aac. 01617-17, 2018 | 48 | 2018 |
| A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis S Sabino, S Soares, F Ramos, M Moretti, AP Zavascki, MH Rigatto MSphere 4 (2), 10.1128/msphere. 00052-19, 2019 | 46 | 2019 |
| Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter … MH Rigatto, VB Ribeiro, D Konzen, AP Zavascki Infection 41, 321-328, 2013 | 31 | 2013 |
| Clinical use of polymyxin B MH Rigatto, DR Falci, AP Zavascki Polymyxin Antibiotics: From Laboratory Bench to Bedside, 197-218, 2019 | 30 | 2019 |
| Clinical features and mortality of patients on renal replacement therapy receiving polymyxin B MH Rigatto, DR Falci, NT Lopes, AP Zavascki International journal of antimicrobial agents 47 (2), 146-150, 2016 | 23 | 2016 |
| Lactobacillus rhamnosus bacteremia in a kidney transplant recipient DR Falci, MH Rigatto, VV Cantarelli, AP Zavascki Transplant Infectious Disease 17 (4), 610-612, 2015 | 17 | 2015 |
| Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity D Rodrigues, GS Baldissera, D Mathos, A Sartori, AP Zavascki, ... Brazilian Journal of Microbiology 52 (4), 1913-1919, 2021 | 14 | 2021 |
| Impact of polymyxin-B-associated acute kidney injury in 1-year mortality and renal function recovery EC Gomes, DR Falci, P Bergo, AP Zavascki, MH Rigatto International journal of antimicrobial agents 52 (1), 86-89, 2018 | 13 | 2018 |
| Polymyxins combined with other antibiotics for the treatment of multi-resistant Gram negative bacteria: review of the literature MH Rigatto, DR Falci Principles and Practice of Clinical Research 2 (1), 2016 | 8 | 2016 |
| Profilaxia pré-exposição no controle do HIV: uma revisão de efetividade e potenciais complicações PHF Bergo, T Bianchini, CG Alves, A Ribeiro Júnior, EK Beck, ... Acta méd.(Porto Alegre), 225-234, 2018 | 5 | 2018 |
| Antimicrobial Therapy Duration for Bloodstream Infections Caused by Pseudomonas aeruginosa or Acinetobacter baumannii-calcoaceticus complex: A … RD Rodrigues, RCL Garcia, GA Bittencourt, VB Waichel, ECL Garcia, ... Antibiotics 12 (3), 538, 2023 | 4 | 2023 |
| Antimicrobial stewardship programme associated with earlier prescription of in vitro susceptible therapy and lower 14-day mortality in patients with carbapenem-resistant … A Barros, H Monroy, P Bergo, E Beck, L David, MH Rigatto Journal of Global Antimicrobial Resistance 28, 130-135, 2022 | 4 | 2022 |
| Renal failure in patients treated with colistin versus polymyxin B: a multicenter prospective cohort study MH Rigatto, MS Oliveira, LV Perdigao-Neto, AS Levin, CM Carrilho, ... Antimicrob Agents Chemother 60 (4), 2443-9, 2016 | 4 | 2016 |
Alexandre ZavasckiUniversidade Federal do Rio Grande do SulVerified email at hcpa.edu.br
